F11 and Stroke: The occurrence of the composite of stroke (ischemic and hemorrhagic) and systemic embolism was not statistically different between FXI inhibitor and DOAC in a random-effect model (OR 2.31, 95%CI 0.57–9.32) but with a heterogeneity of 60% (p = 0.08) (Fig. 3b).